Roche Pharma R&D (pRED)

Our scientists are amongst the best in the industry, discovering and translating cutting-edge science in the pursuit of delivering life-changing benefits to patients.

We continue to be driven by our long-term aim to deliver these medical advances that provide greater benefits to patients, and at the same time, reduce the healthcare burden on society.

pRED's research spans across 6 disease areas: Immunology, Infectious diseases and Ophthalmology, Neuroscience and Rare diseases, and Oncology.

pRED scientists pursue excellence. Patients are waiting, so by pushing boundaries pRED scientists make breakthroughs every day. Found out some examples of areas where pRED is leading the field.

Excellence in science

See all stories

Roche is an innovation company pioneering the future of healthcare, science and R&D.

Roche Pharma Research and Early Development (pRED) scientists are active members of the scientific community and publish in numerous peer-reviewed journals in the areas of Clinical Development, Pharmaceutical Sciences, Therapeutic Modalities and Translational Bioengineering; and Immunology, Infectious diseases and Ophthalmology, Neuroscience and Rare diseases, and Oncology.

See all publications

Roche pRED publications

Revolutionary discoveries in science are truly enabled when we have open minds and ears to share and collaborate.
Hans Clevers
Head of pRED, Roche

At pRED, it’s not the easy questions that excite us, it’s the biggest challenges in healthcare. That’s why we’ve set ourselves big goals to discover treatments that provide greater benefits for patients at a lower cost to society. This means having the expertise, resources and latest technologies at our fingertips, within an organisation that nurtures innovation built on curiosity and responsibility.

Meet Gijs van den Brink, Global Head of Immunology, Infectious Diseases and Ophthalmology, Roche pRED
Meet Madhu Benakareddy, Research Project Leader, Roche pRED
Meet Sascha Fauser, Global Head of Ophthalmology, Roche pRED
Meet the Roche pRED Cancer Immunotherapy Team
Meet the Roche pRED Cancer Immunotherapy Team
Meet a few members of the Roche pRED Oncology Team

Meet the pRED scientists

See all stories
Institute of Human Biology

The Institute of Human Biology (IHB) is dedicated to research on human biology and human model systems such as organoids. Roche Pharmaceutical Research and Early Development (pRED) established the IHB to take maximum advantage of the scientific and research expertise in both academia and the pharmaceutical industry, it will bring them closer together using human model systems to better predict a drug’s validity, and so translate pioneering science into breakthroughs for patients.

More from the Roche Group

Get to know our structure

Discover more